This event is archived. Final snapshot from when the story concluded. View on Dashboard
Events / Business / Johnson & Johnson UK Talc Lawsuit
Business product liability lawsuit

Johnson & Johnson UK Talc Lawsuit

Analysis based on 17 articles · First reported Oct 16, 2025 · Last updated Oct 17, 2025

Sentiment
-70
Attention
6
Articles
17
Market Impact
General
Live prominence charts, article sentiment distribution, and event development timeline available on the Ergen Dashboard
Market Impact

The ongoing lawsuits against Johnson & Johnson and Kenvue, particularly the new £1 billion claim in the United Kingdom, are expected to have a significant negative impact on the stock prices and reputations of both companies. The substantial financial liabilities and legal battles could lead to increased legal provisions and affect investor confidence in the pharmaceutical and consumer goods sectors.

Pharmaceuticals Consumer Goods
Event Summary

Johnson & Johnson and its former consumer health unit Kenvue are facing a mass class-action lawsuit in the United Kingdom, with over 3,000 claimants seeking more than £1 billion in damages. The lawsuit alleges that Johnson & Johnson knowingly sold asbestos-contaminated talcum powder, leading to cases of ovarian cancer and mesothelioma. This UK litigation mirrors tens of thousands of similar lawsuits in the United States, where Johnson & Johnson has already been ordered to pay substantial damages, including a recent $966 million award. Johnson & Johnson stopped selling talc-based baby powder in the US in 2020 and globally in 2023, replacing it with cornstarch. Both Johnson & Johnson and Kenvue deny the allegations, asserting that their talc products were safe and asbestos-free.

Entities Involved
stock
Johnson & Johnson
Johnson & Johnson is facing a mass class-action lawsuit in the United Kingdom and ongoing litigation in the United States over allegations that its talc-based products caused cancer due to asbestos contamination. The company has been ordered to pay significant damages in US cases and faces a potential £1 billion liability in the UK.
Importance 100.0 Sentiment -75.0
stock
Kenvue
Kenvue, formerly Johnson & Johnson's consumer health unit, retained responsibility for talc-related litigation outside the United States and Canada after its spin-off in 2023. It is named as a defendant in the UK lawsuit and maintains that its talc products are safe and asbestos-free.
Importance 80.0 Sentiment -60.0
priv
KP Law
KP Law is the law firm representing the thousands of claimants in the United Kingdom lawsuit against Johnson & Johnson and Kenvue.
Importance 30.0 Sentiment 0.0
per
Janet Fuschillo
Janet Fuschillo is one of the claimants in the UK lawsuit, diagnosed with ovarian cancer after using Johnson & Johnson's baby powder since the 1960s.
Importance 20.0 Sentiment 0.0
per
Patricia Angell
Patricia Angell is a claimant whose husband, Edward, died of mesothelioma, which she attributes to his use of Johnson & Johnson's baby powder.
Importance 20.0 Sentiment 0.0
per
Edward L. Angell
Edward L. Angell, Patricia Angell's husband, died of mesothelioma, with asbestos strains found in his autopsy report linked to contaminated talc.
Importance 10.0 Sentiment 0.0
cnt
United Kingdom
Importance 0.0 Sentiment 0.0
cnt
United States
Importance 0.0 Sentiment 0.0
Relationships
Johnson & Johnson related ↔ Kenvue
Johnson & Johnson related ↔ United States
United Kingdom allies ↔ United States The United Kingdom is a longstanding defense and trade ally of the United States, though it has recently restricted US u
ERGEN INTELLIGENCE
Track this event live

Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.